small molecule

TONMYA

CYCLOBENZAPRINE HYDROCHLORIDE

Loss of exclusivityMarch 2034latest FDA-listed patent expiry

CompanyTONIX PHARMACEUTICALS INC

Drug detail

Brand name	TONMYA
Active ingredient	CYCLOBENZAPRINE HYDROCHLORIDE
Strength	2.8MG
Dosage form	TABLET
Route	SUBLINGUAL
Modality	Small molecule
FDA approval	August 2025
Marketing status	RX

Listed patents

Patent	Expires	Type
10117936	March 2034	product
10864175	March 2034	product
9636408	March 2034	product
9956188	March 2034	product

Regulatory exclusivity

Code	Expires
NP	August 2028

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.